B+
Bull case
25%
Probability
Target price
$75.60
+65.1% vs current
Aggregators show median targets in the mid‑$60s with some higher outliers; market is cautiously positive but sensitive to guidance and seasonality.
No evidence quality warning is currently attached to this memo.
Estimated Q1 2026 earnings release; results and guidance will likely move consensus targets and near-term sentiment [#SERP-2].
Analyst updates after results could shift the consensus range (current median ~$65.52); potential to lift or reduce headline momentum.
Seasonal pest-demand and dividend/share‑repurchase decisions can affect valuation over multiple quarters.
No formal recommendation provided.